Cochran; Michael Caramian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cochran; Michael Caramian.The latest application filed is for "nucleic acid compositions and methods of multi-exon skipping".

Company Profile

21.14.27

Cochran; Michael Caramian - San Diego CA
Cochran; Michael Caramian - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods of treating muscle dystrophy Grant 11,446,387 - Doppalapudi , et al. September 20, 2	2022-09-20
Nucleic acid-polypeptide compositions and methods of inducing exon skipping Grant 11,400,163 - Levin , et al. August 2, 2	2022-08-02
Nucleic Acid Compositions And Methods Of Multi-exon Skipping App 20220235354 - DARIMONT; Beatrice Diana ; et al.	2022-07-28
Nucleic acid-polypeptide compositions and uses thereof Grant 11,364,302 - Geall , et al. June 21, 2	2022-06-21
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220133900 - GEALL; Andrew John ; et al.	2022-05-05
Nucleic acid-polypeptide compositions and methods of inducing exon skipping Grant 11,311,627 - Levin , et al. April 26, 2	2022-04-26
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220096647 - GEALL; Andrew John ; et al.	2022-03-31
Nucleic Acid-polypeptide Compositions And Methods Of Inducing Exon Skipping App 20220072145 - LEVIN; Arthur A. ; et al.	2022-03-10
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220062434 - GEALL; Andrew John ; et al.	2022-03-03
Compositions and methods of treating muscle atrophy and myotonic dystrophy Grant 11,253,607 - Geall , et al. February 22, 2	2022-02-22
Compositions and methods of treating muscle atrophy and myotonic dystrophy Grant 11,246,941 - Geall , et al. February 15, 2	2022-02-15
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220040322 - GEALL; Andrew John ; et al.	2022-02-10
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220040323 - GEALL; Andrew John ; et al.	2022-02-10
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220008550 - GEALL; Andrew John ; et al.	2022-01-13
Nucleic acid-polypeptide compositions and methods of inducing exon skipping Grant 11,179,472 - Levin , et al. November 23, 2	2021-11-23
Compositions And Methods Of Treating Muscle Dystrophy App 20210299266 - DOPPALAPUDI; Venkata Ramana ; et al.	2021-09-30
Nucleic acid-polypeptide compositions and uses thereof Grant 11,110,180 - Geall , et al. September 7, 2	2021-09-07
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20210187116 - GEALL; Andrew John ; et al.	2021-06-24
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20210179720 - GEALL; Andrew John ; et al.	2021-06-17
Nucleic acid-polypeptide compositions and methods of inducing exon skipping Grant 10,994,020 - Levin , et al. May 4, 2	2021-05-04
Heteroduplex Nucleic Acid Molecules And Uses Thereof App 20210095283 - GEALL; Andrew John ; et al.	2021-04-01
Compositions and methods of treating muscle atrophy and myotonic dystrophy Grant 10,881,743 - Geall , et al. January 5, 2	2021-01-05
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20200405877 - GEALL; Andrew John ; et al.	2020-12-31
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20200385414 - DOPPALAPUDI; Venkata Ramana ; et al.	2020-12-10
Una Amidites And Uses Thereof App 20200385725 - DOPPALAPUDI; Venkata Ramana ; et al.	2020-12-10
Nucleic acid-polypeptide compositions and uses thereof Grant 10,800,848 - Geall , et al. October 13, 2	2020-10-13
Nucleic acid-polypeptide compositions and uses thereof Grant 10,787,519 - Geall , et al. September 29, 2	2020-09-29
Nucleic Acid-polypeptide Compositions And Methods Of Inducing Exon Skipping App 20200282074 - LEVIN; Arthur A. ; et al.	2020-09-10
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20200123261 - GEALL; Andrew John ; et al.	2020-04-23
Nucleic acid-polypeptide compositions and uses thereof Grant 10,550,188 - Geall , et al. Fe	2020-02-04
Nucleic acid-polypeptide compositions and uses thereof Grant 10,487,149 - Geall , et al. Nov	2019-11-26
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20190298847 - GEALL; Andrew John ; et al.	2019-10-03
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20190192681 - GEALL; Andrew John ; et al.	2019-06-27
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20190062435 - GEALL; Andrew John ; et al.	2019-02-28
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20190062436 - GEALL; Andrew John ; et al.	2019-02-28
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20190062437 - GEALL; Andrew John ; et al.	2019-02-28
Nucleic Acid-polypeptide Compositions And Methods Of Inducing Exon Skipping App 20190000986 - Levin; Arthur A. ; et al.	2019-01-03
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20190000987 - GEALL; Andrew John ; et al.	2019-01-03
Nucleic Acid-polypeptide Compositions And Methods Of Inducing Exon Skipping App 20180369400 - LEVIN; Arthur A. ; et al.	2018-12-27
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20180371102 - GEALL; Andrew John ; et al.	2018-12-27
Nucleic Acid-polypeptide Compositions And Uses Thereof App 20170281795 - GEALL; Andrew John ; et al.	2017-10-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.